Main Banner Desktop
hebeilangland

Hebei Langland

Unverified company Unverified company
  • Imagem 1

South Korea Bo tox nabota nabota botulax medixtion innotox Botulinum Toxin


Unit Price:

USD 0,30

FOB Price:

USD 0,30

Minimum Order Quantity:

1 Box

Type of Payment:

L/C (Letter of Credit)

D/A (Documents Against Acceptance)

D/P (Documents Against Payment)

T/T (Wire Transfer)

Others

Preferred Port:

Not informed

Reference:

Not informed


Description

Product Description
It is an injectable solution for adult patients seeking to temporarily improve, remove and correct signs of aging, but it can be used as a treatment method for TMJ, blood spasm, and bleach.

Made in Korea, it is composed of 100 sets of Bot A toxic substances. Other ingredients: sodium chloride (tonicity agent) and human serum albumin (stabilizer).

According to the health, safety and quality standards and regulations of most countries, we regularly produce materials and ingredients for manufacturing treatments,

The product can be stored in a refrigerator at 8 to 12 degrees C °, or stored frozen at a temperature below -5 degrees Celsius.

  • nabota
  • nabota
  • botulax
  • medixtion
  • innotox
  • Botulinum Toxin

Production Capacity:

1000000

Delivery Timeframe:

Within 30 Days

Incoterms:

DDP - Delivered Duty Paid

Packaging Details:

Not informed


More about
Hebei Langland

icone de usuario

50-100

Employees

sales icon

10M - 50M

Sales volume (USD)

icone de exportar

80%

% Export sales

2007

Year

Established


Business type
  • Distributor / Wholesaler

Keywords
  • Korea Botox
  • South Korea HA Filler
  • Skin Booster
  • PDRN Filler
  • PLLA Filler
  • FAT Slimming Solution
  • Skin White Product
  • placenta
  • anesthesia cream
  • Ver Mais

Contact and location
  • icone de usuario Mona Han
  • icone de telefone +86 xxxxxxxx
  • map-marker 石家庄 / 河北 | China

Make your Request!

Make your Request!

Start conversation
logo-Whatsapp icon-checked-none

Hello 👋!
Can we help you?

Fill in your name and phone number 😁

Start conversation Start conversation